Rijnstra ES

No ORCID on file · 1 paper in corpus
2024
Frontiers in immunology ·doi:10.3389/fimmu.2024.1415457

BackgroundThe occurrence of peritoneal metastasis (PM) in patients with colorectal cancer (CRC) has a dismal prognosis. There is often limited response to systemic- and immunotherapy, even in microsatellite unstable (MSI) CRC. To overcome t…